|
1
|
Nguyen LT, Chen H, Pollock C and Saad S:
SIRT1 reduction is associated with sex-specific dysregulation of
renal lipid metabolism and stress responses in offspring by
maternal high-fat diet. Sci Rep. 7:89822017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chan SH, Hung CH, Shih JY, Chu PM, Cheng
YH, Lin HC and Tsai KL: SIRT1 inhibition causes oxidative stress
and inflammation in patients with coronary artery disease. Redox
Biol. 13:301–309. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang J, Kim TH, Ahn MY, Lee J, Jung JH,
Choi WS, Lee BM, Yoon KS, Yoon S and Kim HS: Sirtinol, a class III
HDAC inhibitor, induces apoptotic and autophagic cell death in
MCF-7 human breast cancer cells. Int J Oncol. 41:1101–1109. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Park EY, Woo Y, Kim SJ, Kim DH, Lee EK, De
U, Kim KS, Lee J, Jung JH, Ha KT, et al: Anticancer effects of a
new SIRT inhibitor, MHY2256, against human breast cancer MCF-7
cells via regulation of MDM2-p53 binding. Int J Biol Sci.
12:1555–1567. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Peck B, Chen CY, Ho KK, Di Fruscia P,
Myatt SS, Coombes RC, Fuchter MJ, Hsiao CD and Lam EW: SIRT
inhibitors induce cell death and p53 acetylation through targeting
both SIRT1 and SIRT2. Mol Cancer Ther. 9:844–855. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kim HB, Lee SH, Um JH, Oh WK, Kim DW, Kang
CD and Kim SH: Sensitization of multidrug-resistant human cancer
cells to Hsp90 inhibitors by downregulation of SIRT1. Oncotarget.
6:36202–36218. 2015.PubMed/NCBI
|
|
7
|
Kim TH and Kim HS, Kang YJ, Yoon S, Lee J,
Choi WS, Jung JH and Kim HS: Psammaplin A induces Sirtuin
1-dependent autophagic cell death in doxorubicin-resistant
MCF-7/adr human breast cancer cells and xenografts. Biochim Biophys
Acta. 1850:401–410. 2015. View Article : Google Scholar
|
|
8
|
Chu F, Chou PM, Zheng X, Mirkin BL and
Rebbaa A: Control of multidrug resistance gene mdr1 and cancer
resistance to chemotherapy by the longevity gene sirt1. Cancer Res.
65:10183–10187. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Smith WL: Prostanoid biosynthesis and
mechanisms of action. Am J Physiol. 263:F181–F191. 1992.PubMed/NCBI
|
|
10
|
Straus DS, Pascual G, Li M, Welch JS,
Ricote M, Hsiang CH, Sengchanthalangsy LL, Ghosh G and Glass CK:
15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in
the NF-kappa B signaling pathway. Proc Natl Acad Sci USA.
97:4844–4849. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cho WH, Choi CH, Park JY, Kang SK and Kim
YK: 15-deoxy-(Delta12,14)-prostaglandin J2 (15d-PGJ2)
induces cell death through caspase-independent mechanism in A172
human glioma cells. Neurochem Res. 31:1247–1254. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
de Jong E, Winkel P, Poelstra K and
Prakash J: Anticancer effects of 15d-prostaglandin-J2 in
wild-type and doxorubicin-resistant ovarian cancer cells: Novel
actions on SIRT1 and HDAC. PLoS One. 6:e251922011. View Article : Google Scholar
|
|
13
|
Ahmad P, Rasool S, Gul A, Sheikh SA, Akram
NA, Ashraf M, Kazi AM and Gucel S: Jasmonates: Multifunctional
roles in stress tolerance. Front Plant Sci. 7:8132016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dang HT, Lee HJ, Yoo ES, Hong J, Bao B,
Choi JS and Jung JH: New jasmonate analogues as potential
anti-inflammatory agents. Bioorg Med Chem. 16:10228–10235. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Choo J, Lee Y, Yan XJ, Noh TH, Kim SJ, Son
S, Pothoulakis C, Moon HR, Jung JH and Im E: A novel peroxisome
proliferator-activated receptor (PPAR)γ agonist 2-hydroxyethyl
5-chloro-4,5-didehydrojasmonate exerts anti-inflammatory effects in
colitis. J Biol Chem. 290:25609–25619. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
LigPrep, version 2.5. Schrödinger, LLC;
New York: 2011
|
|
17
|
Tripathi SK, Muttineni R and Singh SK:
Extra precision docking, free energy calculation and molecular
dynamics simulation studies of CDK2 inhibitors. J Theor Biol.
334:87–100. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Friesner RA, Banks JL, Murphy RB, Halgren
TA, Klicic JJ, Mainz DT, Repasky MP, Knoll EH, Shelley M, Perry JK,
et al: Glide: A new approach for rapid, accurate docking and
scoring. 1. Method and assessment of docking accuracy. J Med Chem.
47:1739–1749. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Friesner RA, Murphy RB, Repasky MP, Frye
LL, Greenwood JR, Halgren TA, Sanschagrin PC and Mainz DT: Extra
precision glide: Docking and scoring incorporating a model of
hydro-phobic enclosure for protein-ligand complexes. J Med Chem.
49:6177–6196. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Halgren TA, Murphy RB, Friesner RA, Beard
HS, Frye LL, Pollard WT and Banks JL: Glide: A new approach for
rapid, accurate docking and scoring. 2. Enrichment factors in
database screening. J Med Chem. 47:1750–1759. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jacobson MP, Pincus DL, Rapp CS, Day TJ,
Honig B, Shaw DE and Friesner RA: A hierarchical approach to
all-atom protein loop prediction. Proteins. 55:351–367. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Murugan S and Amaravadi RK: Methods for
studying autophagy within the tumor microenvironment. Adv Exp Med
Biol. 899:145–166. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chalkiadaki A and Guarente L: The
multifaceted functions of sirtuins in cancer. Nat Rev Cancer.
15:608–624. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pierzyńska-Mach A, Janowski PA and
Dobrucki JW: Evaluation of acridine orange, LysoTracker Red, and
quinacrine as fluorescent probes for long-term tracking of acidic
vesicles. Cytometry A. 85:729–737. 2014. View Article : Google Scholar
|
|
25
|
Shingu T, Fujiwara K, Bögler O, Akiyama Y,
Moritake K, Shinojima N, Tamada Y, Yokoyama T and Kondo S:
Inhibition of autophagy at a late stage enhances imatinib-induced
cytotoxicity in human malignant glioma cells. Int J Cancer.
124:1060–1071. 2009. View Article : Google Scholar
|
|
26
|
Paglin S, Hollister T, Delohery T, Hackett
N, McMahill M, Sphicas E, Domingo D and Yahalom J: A novel response
of cancer cells to radiation involves autophagy and formation of
acidic vesicles. Cancer Res. 61:439–444. 2001.PubMed/NCBI
|
|
27
|
de Duve C, de Barsy T, Poole B, Trouet A,
Tulkens P and Van Hoof F: Commentary. Lysosomotropic agents.
Biochem Pharmacol. 23:2495–2531. 1974. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
He S, He C, Yuan H, Xiong S, Xiao Z and
Chen L: The SIRT 3 expression profile is associated with
pathological and clinical outcomes in human breast cancer patients.
Cell Physiol Biochem. 34:2061–2069. 2014. View Article : Google Scholar
|
|
29
|
Wang P, Lv C, Zhang T, Liu J, Yang J, Guan
F and Hong T: FOXQ1 regulates senescence-associated inflammation
via activation of SIRT1 expression. Cell Death Dis. 8:e29462017.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen J, Zhang B, Wong N, Lo AW, To KF,
Chan AW, Ng MH, Ho CY, Cheng SH, Lai PB, et al: Sirtuin 1 is
upregulated in a subset of hepatocellular carcinomas where it is
essential for telomere maintenance and tumor cell growth. Cancer
Res. 71:4138–4149. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ota H, Tokunaga E, Chang K, Hikasa M,
Iijima K, Eto M, Kozaki K, Akishita M, Ouchi Y and Kaneki M: Sirt1
inhibitor, Sirtinol, induces senescence-like growth arrest with
attenuated Ras-MAPK signaling in human cancer cells. Oncogene.
25:176–185. 2006. View Article : Google Scholar
|
|
32
|
Lin Z and Fang D: The roles of SIRT1 in
cancer. Genes Cancer. 4:97–104. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lee JT and Gu W: SIRT1: Regulator of p53
deacetylation. Genes Cancer. 4:112–117. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yang ZJ, Chee CE, Huang S and Sinicrope
FA: The role of autophagy in cancer: Therapeutic implications. Mol
Cancer Ther. 10:1533–1541. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sever ON and Demir OG: Autophagy: Cell
death or survive mechanism. J Oncol Sci. 3:37–44. 2017.
|
